| Version |
2.5 |
| Creation Date |
2005-11-16 15:48:42 |
| Update Date |
2009-05-05 20:58:37 |
| Accession Number |
HMDB01264 |
| Secondary Accession Numbers |
Not Available |
| Common Name |
Dehydroascorbic acid |
| Description |
Dehydroascorbic acid is the oxidized form of vitamin C. Reduced Vitamin C concentrations in the brain exceed those in blood by 10 fold. Dehydroascorbic acid readily enters the brain and is retained in the brain tissue in the form of ascorbic acid (ascorbic acid is not able to cross the blood-brain barrier).
Therefore, transport of dehydroascorbic acid by the Glucose Transporter 1 (GLUT1, Glucose transporters are integral membrane glycoproteins involved in transporting glucose into most cells. GLUT1 is a major glucose transporter in the mammalian blood-brain barrier. It is present at high levels in primate erythrocytes and brain endothelial cells.) is a mechanism by which the brain acquires vitamin C. (OMIM 138140) |
| Synonyms |
- 1-Dehydroascorbate
- 1-Dehydroascorbic acid
- DHAA
- Dehydro-L-ascorbate
- Dehydro-L-ascorbic acid
- Dehydroascorbate
- L-Dehydroascorbate
- L-Dehydroascorbic acid
- L-Threo-hexo-2,3-diulosono-1,4-lactone
- L-threo-2,3-Hexodiulosonic acid gamma-lactone
- Oxidized ascorbate
- Oxidized ascorbic acid
- Oxidized vitamin C
|
| Chemical IUPAC Name |
5-(1,2-dihydroxyethyl)oxolane-2,3,4-trione |
| Chemical Formula |
C6H6O6 |
| Chemical Structure |
 |
| Chemical Taxonomy |
| Kingdom |
|
| Super Class |
- Carbohydrates and Carbohydrate conjugates
|
| Class |
|
| Sub Class |
|
| Family |
|
| Species |
- ketone
- primary alcohol
- secondary alcohol
- 1,2-diol
- carboxylic acid ester
- lactone
- heterocyclic compound
|
| Biofunction |
- Component of Tyrosine metabolism
|
| Application |
| — |
| Source |
|
|
| Average Molecular Weight |
174.108 |
| Monoisotopic Molecular Weight |
174.016434 |
| Isomeric SMILES |
OC[C@@H](O)[C@H]1OC(=O)C(=O)C1=O |
| Canonical SMILES |
OCC(O)C1OC(=O)C(=O)C1=O |
| KEGG Compound ID |
C00425  |
| BioCyc ID |
L-DEHYDRO-ASCORBATE  |
| BiGG ID |
34945  |
| Wikipedia Link |
Dehydroascorbic acid  |
| NuGOwiki Link |
HMDB01264  |
| Metagene Link |
HMDB01264  |
| METLIN ID |
342  |
| PubChem Compound |
10280  |
| PubChem Substance |
8157415  |
| ChEBI ID |
17242  |
| CAS Registry Number |
490-83-5 |
| InChI Identifier |
InChI=1/C6H6O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-8H,1H2/t2-,5-/m1/s1 |
| Synthesis Reference |
Utsumi, Isamu; Harada, Kiyoshi; Miura, Hiroshi. Dehydroascorbic acid. Jpn. Tokkyo Koho (1972), 2 pp. |
| Melting Point (Experimental) |
Not Available |
| Experimental Water Solubility |
Not Available
Source: PhysProp
|
| Predicted Water Solubility |
1000.0 mg/mL [MEYLAN,WM et al. (1996)]; 190.0 mg/mL [Predicted by ALOGPS]
Calculated using ALOGPS
|
| Physiological Charge |
-1 |
| State |
Solid |
| Experimental LogP/Hydrophobicity |
Not Available
Source: PhysProp
|
| Predicted LogP/Hydrophobicity |
-1.17 [Predicted by ALOGPS]; -1.9 [Predicted by PubChem via XLOGP]; -1.80 [MEYLAN,WM & HOWARD,PH (1995)]
Calculated using ALOGPS
|
| Material Safety Data Sheet (MSDS) |
|
| MOL File |
Show  |
| SDF File |
Show  |
| PDB File |
Show  |
| 2D Structure |
|
| 3D Structure |
|
| Experimental PDB ID |
Not Available |
| Experimental 1H NMR Spectrum |
Download Spectrum Download FID (Bruker) Show Experimental Conditions  |
| Experimental 13C NMR Spectrum |
Not Available |
| Experimental 13C HSQC Spectrum |
Download Spectrum Download FID (Bruker) Show Experimental Conditions  |
| Predicted 1H NMR Spectrum |
Show Image Show Peaklist
|
| Predicted 13C NMR Spectrum |
Show Image Show Peaklist
|
| Mass Spectrum |
|
| Simplified TOCSY Spectrum |
Not Available |
| BMRB Spectrum |
Not Available |
| Cellular Location |
|
| Biofluid Location |
|
| Tissue Location |
| Tissue |
References |
| Blood |
— |
| Brain |
— |
| Erythrocyte |
— |
| Intestine |
— |
| Placenta |
— |
| Platelet |
— |
|
| Concentrations (Normal) |
| Biofluid |
Blood |
| Value |
2.32 +/- 0.78 uM |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Patient information |
Smoker |
| Comments |
Not Available |
| References |
- Lykkesfeldt J, Loft S, Nielsen JB, Poulsen HE: Ascorbic acid and dehydroascorbic acid as biomarkers of oxidative stress caused by smoking. Am J Clin Nutr. 1997 Apr;65(4):959-63. [PubMed
]
|
| Biofluid |
Blood |
| Value |
2.36 +/- 0.11 uM |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Patient information |
Non-smoker |
| Comments |
Not Available |
| References |
- Lykkesfeldt J, Loft S, Nielsen JB, Poulsen HE: Ascorbic acid and dehydroascorbic acid as biomarkers of oxidative stress caused by smoking. Am J Clin Nutr. 1997 Apr;65(4):959-63. [PubMed
]
|
|
| Concentrations (Abnormal) |
Not Available |
| Associated Disorders |
Not Available |
| OMIM ID |
Not Available |
| Pathways |
|
| General References |
- Raghavan SA, Sharma P, Dikshit M: Role of ascorbic acid in the modulation of inhibition of platelet aggregation by polymorphonuclear leukocytes. Thromb Res. 2003 May 1;110(2-3):117-26. [PubMed
]
- Kuo SM, Tan D, Boyer JC: Cellular vitamin C accumulation in the presence of copper. Biol Trace Elem Res. 2004 Aug;100(2):125-36. [PubMed
]
- Bakaev VV, Duntau AP: Ascorbic acid in blood serum of patients with pulmonary tuberculosis and pneumonia. Int J Tuberc Lung Dis. 2004 Feb;8(2):263-6. [PubMed
]
- Toivola DM, Isomaa B: Effects of dehydroabietic acid on the erythrocyte membrane. Chem Biol Interact. 1991;79(1):65-78. [PubMed
]
- Dhariwal KR, Hartzell WO, Levine M: Ascorbic acid and dehydroascorbic acid measurements in human plasma and serum. Am J Clin Nutr. 1991 Oct;54(4):712-6. [PubMed
]
- Trepanier LA, Yoder AR, Bajad S, Beckwith MD, Bellehumeur JL, Graziano FM: Plasma ascorbate deficiency is associated with impaired reduction of sulfamethoxazole-nitroso in HIV infection. J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1041-50. [PubMed
]
- Mendiratta S, Qu ZC, May JM: Erythrocyte ascorbate recycling: antioxidant effects in blood. Free Radic Biol Med. 1998 Mar 15;24(5):789-97. [PubMed
]
- Padilla CA, Spyrou G, Holmgren A: High-level expression of fully active human glutaredoxin (thioltransferase) in E. coli and characterization of Cys7 to Ser mutant protein. FEBS Lett. 1996 Jan 2;378(1):69-73. [PubMed
]
- Shugalei IuS, Degtiar VV, Butvin IN, Grivenko GP: [Effect of alcohol intoxication on ascorbic and dehydroascorbic acid levels in rat tissue. and human blood] Ukr Biokhim Zh. 1986 May-Jun;58(3):81-3. [PubMed
]
- Bakaev VV, Efremov AV, Tityaev II: Low levels of dehydroascorbic acid in uraemic serum and the partial correction of dehydroascorbic acid deficiency by haemodialysis. Nephrol Dial Transplant. 1999 Jun;14(6):1472-4. [PubMed
]
- Margolis SA, Ziegler RG, Helzlsouer KJ: Ascorbic and dehydroascorbic acid measurement in human serum and plasma. Am J Clin Nutr. 1991 Dec;54(6 Suppl):1315S-1318S. [PubMed
]
- Davis JL Jr, Mendiratta S, May JM: Similarities in the metabolism of alloxan and dehydroascorbate in human erythrocytes. Biochem Pharmacol. 1998 Apr 15;55(8):1301-7. [PubMed
]
- Wells WW, Xu DP, Yang YF, Rocque PA: Mammalian thioltransferase (glutaredoxin) and protein disulfide isomerase have dehydroascorbate reductase activity. J Biol Chem. 1990 Sep 15;265(26):15361-4. [PubMed
]
- Dubey SS, Palodhi GR, Jain AK: Ascorbic acid, dehydroascorbic acid and glutathione in liver disease. Indian J Physiol Pharmacol. 1987 Oct-Dec;31(4):279-83. [PubMed
]
- May JM, Qu ZC, Whitesell RR, Cobb CE: Ascorbate recycling in human erythrocytes: role of GSH in reducing dehydroascorbate. Free Radic Biol Med. 1996;20(4):543-51. [PubMed
]
- Wikipedia

|